Hereditary Apolipoprotein A-I-Associated Cardiac Amyloidosis: Importance of Endomyocardial Biopsy When Suspicion Remains High.
JACC Case Rep
; 3(7): 1032-1037, 2021 Jul 07.
Article
em En
| MEDLINE
| ID: mdl-34317679
ABSTRACT
Cardiac amyloidosis has recently garnered substantial attention. Although the advent of noninvasive diagnostic algorithms revolutionized diagnosis, endomyocardial biopsy may still be considered in select cases to determine the amyloidosis subtype definitively. We report a case of a patients with a known mutation causing hereditary apolipoprotein A-I-associated cardiac amyloidosis. (Level of Difficulty Advanced.).
AApo A-I, amyloid apolipoprotein A-I; AL, immunoglobulin light chain; ATTR, amyloid transthyretin; CA, cardiac amyloidosis; CMR, cardiac magnetic resonance; EMB, endomyocardial biopsy; HCM, hypertrophic cardiomyopathy; HFpEF, heart failure with preserved ejection fraction; LC MS/MS, liquid chromatography tandem mass spectrometry; apolipoprotein; endomyocardial biopsy; infiltrative cardiomyopathy
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Tipo de estudo:
Risk_factors_studies
Idioma:
En
Revista:
JACC Case Rep
Ano de publicação:
2021
Tipo de documento:
Article
País de afiliação:
Estados Unidos